Wilson Sonsini Goodrich & Rosati
Palo Alto, California, United StatesFounded 1961
Wilson Sonsini Goodrich & Rosati primarily focuses on advising high-growth companies, particularly in the technology, life sciences, and emerging industries sectors. Their strategy involves representing entrepreneurs and venture-backed companies throughout their lifecycle, from initial financing and corporate transactions to IPOs and M&A, while also counseling venture capital firms on investment and governance matters.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (50% of deals). Average disclosed round size is $9.6M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCaptain Experiences | Seed | $2M | Feb 2022 |
 BioSkryb | Seed | $11.5M | Jan 2020 |
 DotLab | Series A | $10M | Jul 2019 |
 Blast | Seed | $5M | Mar 2018 |
 Cofactor Genomics | Series A | $18M | Sep 2017 |
 Movable Ink | Series B | $11M | May 2013 |
Top Co-Investors
Anzu Partners1 shared
Looking Glass1 shared
Andreessen Horowitz1 shared
Not Boring Capital1 shared
Goodwater Capital1 shared
Correlation Ventures1 shared
TechNexus Venture Collaborative1 shared
Factory1 shared
Menlo Ventures1 shared
Y Combinator1 shared
DCVC1 shared
Ascension Ventures1 shared
iSelect Fund1 shared
Tiger Global Management1 shared
Luxor Capital Group1 shared
Core Innovation Ventures1 shared
Great Oaks1 shared
Intel Capital1 shared
Contour Venture Partners1 shared
Metamorphic Ventures1 shared
Last updated: 16 April 2026